Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Verma

Showing results (341-350 of 459) with videos related to

Pageof 46
Sort By:
Biotechnology Reports (Amsterdam, Netherlands)|May 24, 2021
Isolation and enzyme bioprospection of bacteria associated to <i>Bruguiera cylindrica</i>, a mangrove plant of North Sumatra, IndonesiaJendri Mamangkey, Dwi Suryanto, Erman Munir, et al.
Blood|August 31, 2006
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitorsTony A Navas, Mani Mohindru, Myka Estes, et al.
Leukemia & Lymphoma|July 9, 2019
HIV portends a poor prognosis in myelodysplastic syndromesJustin D Kaner, Santiago Thibaud, Sakshi Jasra, et al.
Blood Cancer Journal|August 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratificationRajvi Gor, Jeevan Shivakumar, Pallavi Surana, et al.
Journal of Hematology & Oncology|May 23, 2022
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Xiaoyi Chen, Huamin Wang, et al.
Journal of Hematology & Oncology|July 26, 2022
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Xiaoyi Chen, Huamin Wang, et al.
Annals of Hematology|April 30, 2022
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromesMikkael A Sekeres, Michael Schuster, Magalie Joris, et al.
Nature Immunology|April 9, 2013
Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitmentBritta Will, Thomas O Vogler, Boris Bartholdy, et al.
Cancer Research|October 16, 2012
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasmsSangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, et al.
Iscience|June 20, 2020
Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response DynamicsMunisha Smalley, Michelle Przedborski, Saravanan Thiyagarajan, et al.
Pageof 46

Showing results (341-350 of 459) with videos related to

Sort By:
Pageof 46
Biotechnology Reports (Amsterdam, Netherlands)|May 24, 2021
Isolation and enzyme bioprospection of bacteria associated to <i>Bruguiera cylindrica</i>, a mangrove plant of North Sumatra, IndonesiaJendri Mamangkey, Dwi Suryanto, Erman Munir, et al.
Blood|August 31, 2006
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitorsTony A Navas, Mani Mohindru, Myka Estes, et al.
Leukemia & Lymphoma|July 9, 2019
HIV portends a poor prognosis in myelodysplastic syndromesJustin D Kaner, Santiago Thibaud, Sakshi Jasra, et al.
Blood Cancer Journal|August 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratificationRajvi Gor, Jeevan Shivakumar, Pallavi Surana, et al.
Journal of Hematology & Oncology|May 23, 2022
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Xiaoyi Chen, Huamin Wang, et al.
Journal of Hematology & Oncology|July 26, 2022
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancerYang Zhang, Xiaoyi Chen, Huamin Wang, et al.
Annals of Hematology|April 30, 2022
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromesMikkael A Sekeres, Michael Schuster, Magalie Joris, et al.
Nature Immunology|April 9, 2013
Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitmentBritta Will, Thomas O Vogler, Boris Bartholdy, et al.
Cancer Research|October 16, 2012
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasmsSangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, et al.
Iscience|June 20, 2020
Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response DynamicsMunisha Smalley, Michelle Przedborski, Saravanan Thiyagarajan, et al.
Pageof 46